Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

Citarella BW. et al, (2024), Heliyon, e29591 - e29591

Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study.

Reyes LF. et al, (2023), J Crit Care, 77

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera.

Roper KJ. et al, (2023), Sci Rep, 13

Standardized data collection can lead to more insightful outcomes

LEE J., (2023), British Journal of Sports Medicine

Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases

Hassoun-Kheir N. et al, (2022), Clinical Microbiology and Infection, 28, 1528 - 1532

Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study

Vink E. et al, (2022), Open Forum Infectious Diseases, 9

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.

ISARIC Clinical Characterization Group None. et al, (2022), Sci Data, 9

Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.

Wainstein M. et al, (2022), PLoS Med, 19

Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

Leclerc QJ. et al, (2021), BMC Health Services Research, 21

The value of open-source clinical science in pandemic response: lessons from ISARIC

Abbas A. et al, (2021), The Lancet Infectious Diseases, 21, 1623 - 1624

A prenylated dsRNA sensor protects against severe COVID-19

Wickenhagen A. et al, (2021), Science, 374

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Drake TM. et al, (2021), The Lancet, 398, 223 - 237

Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: an observational cohort

Hall M., (2021)

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

Gupta RK. et al, (2021), The Lancet Respiratory Medicine, 9, 349 - 359

Preparing for a pandemic: highlighting themes for research funding and practice—perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)

Norton A. et al, (2020), BMC Medicine, 18

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

Thompson CP. et al, (2020), Eurosurveillance, 25

ISARIC COVID-19 Clinical Data Report issued: 27 March 2022

Baillie JK. et al, (2020)

Global outbreak research: harmony not hegemony

Akhvlediani T. et al, (2020), The Lancet Infectious Diseases, 20, 770 - 772

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Docherty AB. et al, (2020), BMJ, m1985 - m1985

Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

Docherty AB. et al, (2020)

Load More

Include forthcoming?